Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder

► Behavioural effects of monoamine reuptake inhibitors (MARI) were examined in an ADHD model rat. ► MARI had differential therapeutic potentials on ADHD-like behavioural domains. ► The heterogeneity of monoaminergic systems may be involved in the symptomatic domains of ADHD.